share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LEIDEN JEFFREY M

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LEIDEN JEFFREY M

福泰制药 | 4:持股变动声明-高管 LEIDEN JEFFREY M
美股SEC公告 ·  09/04 16:21

Moomoo AI 已提取核心信息

Vertex Pharmaceuticals Executive Chairman, JEFFREY M LEIDEN, completed a sale of 3,784 shares of the company's common stock on August 30, 2024. The transaction was executed at a price of $499 per share, resulting in a total sale value of $1,888,216. Following the sale, LEIDEN's direct holdings in Vertex Pharmaceuticals stand at 9,994 shares. Additionally, LEIDEN holds an indirect position of 440 shares through a 401(k) plan. The sale took place in the open market and was part of a planned disposition of shares.
Vertex Pharmaceuticals Executive Chairman, JEFFREY M LEIDEN, completed a sale of 3,784 shares of the company's common stock on August 30, 2024. The transaction was executed at a price of $499 per share, resulting in a total sale value of $1,888,216. Following the sale, LEIDEN's direct holdings in Vertex Pharmaceuticals stand at 9,994 shares. Additionally, LEIDEN holds an indirect position of 440 shares through a 401(k) plan. The sale took place in the open market and was part of a planned disposition of shares.
福泰制药执行主席JEFFREY m LEIDEN于2024年8月30日完成了对公司普通股的3,784股的出售。交易价格为每股499美元,总销售价值为1,888,216美元。出售后,LEIDEN在福泰制药的直接持股为9,994股。此外,LEIDEN还通过401(k)计划持有440股的间接股位。该交易是在公开市场进行的,并且是计划中的股份处置的一部分。
福泰制药执行主席JEFFREY m LEIDEN于2024年8月30日完成了对公司普通股的3,784股的出售。交易价格为每股499美元,总销售价值为1,888,216美元。出售后,LEIDEN在福泰制药的直接持股为9,994股。此外,LEIDEN还通过401(k)计划持有440股的间接股位。该交易是在公开市场进行的,并且是计划中的股份处置的一部分。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息